Result of AGM

RNS Number : 3240L
AstraZeneca PLC
24 April 2015
 



ASTRAZENECA PLC - ANNUAL GENERAL MEETING 2015

 

Results of Annual General Meeting held on 24 April 2015

 

AstraZeneca PLC announced the results of the voting at its Annual General Meeting today.  As proposed in the Notice of AGM, all Resolutions were decided by poll vote. Resolutions 1 - 8 were passed as ordinary resolutions and resolutions 9 - 12 were passed as special resolutions.

 

 


RESOLUTION

VOTES FOR

% OF VOTES CAST

VOTES AGAINST

% OF VOTES CAST

VOTES CAST IN TOTAL

TOTAL VOTES CAST AS A % OF ISSUED SHARE CAPITAL

VOTES WITHHELD

1

To receive the Company's Accounts and the Reports of the Directors and Auditor for the year ended 31 December 2014

 

877,576,463

99.67

2,921,581

0.33

880,498,044

69.68%

10,675,935

2

To confirm dividends

 

886,527,613

99.66

2,986,602

0.34

889,514,215

70.40%

1,659,763

3

To re-appoint KPMG LLP, London as Auditor

 

876,751,815

98.61

12,397,571

1.39

889,149,386

70.37%

2,024,593

4

To authorise the Directors to agree the remuneration of the Auditor

 

887,495,062

99.82

1,629,520

0.18

889,124,582

70.37%

2,049,398

5a

To re-elect Leif Johansson as a Director

 

851,461,560

95.76

37,705,142

4.24

889,166,702

70.37%

2,007,277

5b

To re-elect Pascal Soriot as a Director

 

888,590,119

99.95

426,241

0.05

889,016,360

70.36%

2,157,620

5c

To re-elect Marc Dunoyer as a Director

 

885,602,969

99.62

3,374,856

0.38

888,977,825

70.36%

2,196,155

5d

To elect Cori Bargmann as a Director

 

888,638,513

99.96

351,446

0.04

888,989,959

70.36%

2,184,021

5e

To re-elect Geneviève Berger as a Director

 

888,552,754

99.95

465,106

0.05

889,017,860

70.36%

2,156,120

5f

To re-elect Bruce Burlington as a Director

 

880,639,560

99.88

1,091,107

0.12

881,730,667

69.78%

9,443,312

5g

To re-elect Ann Cairns as a Director

 

888,587,093

99.95

465,731

0.05

889,052,824

70.36%

2,121,156

5h

To re-elect Graham Chipchase as a Director

 

876,994,757

99.46

4,732,631

0.54

881,727,388

69.78%

9,445,684

5i

To re-elect Jean-Philippe Courtois as a Director

 

880,585,784

99.87

1,137,760

0.13

881,723,544

69.78%

9,450,753

5j

To re-elect Rudy Markham as a Director

 

855,335,488

99.27

6,300,712

0.73

861,636,200

68.19%

29,537,348

5k

To re-elect Shriti Vadera as a Director

 

888,387,120

99.93

582,556

0.07

888,969,676

70.36%

2,204,192

5l

To re-elect Marcus Wallenberg as a Director

 

846,091,821

98.19

15,599,701

1.81

861,691,522

68.20%

29,482,025

6

To approve the Annual Report on Remuneration for the year ended 31 December 2014

739,049,685

84.11

139,601,566

15.89

878,651,251

69.54%

12,522,725

7

To authorise limited EU political donations

 

859,081,444

97.36

23,307,997

2.64

882,389,441

69.83%

8,784,535

8

To authorise the Directors to allot shares

 

808,454,239

91.14

78,551,101

8.86

887,005,340

70.20%

4,168,208

9

To authorise the Directors to disapply pre-emption rights

 

875,263,416

98.61

12,347,679

1.39

887,611,095

70.25%

3,562,455

10

To authorise the Company to purchase its own shares

 

876,130,644

98.54

13,023,264

1.46

889,153,908

70.37%

2,019,960

11

To reduce the notice period for general meetings

 

778,280,838

87.53

110,881,255

12.47

889,162,093

70.37%

2,011,885

12

To adopt new Articles of Association

886,456,629

99.90

900,552

0.10

887,357,181

70.23%

3,813,971

 

 

 

Issued capital

As at 22 April 2015, the number of issued shares of the Company was 1,263,544,938, ordinary shares, which was the total number of shares entitling the holders to attend and vote for or against all the resolutions at the AGM.  In accordance with the Company's Articles of Association, on a poll every member present in person or by proxy has one vote for every share held.

 

 

A C N Kemp

Company Secretary

24 April 2015


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RAGPGUQCCUPAGAC

Companies

AstraZeneca (AZN)
UK 100

Latest directors dealings